| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | <=2 |
| Aztreonam | Resistant | 32 |
| Cefepime | Resistant | 32 |
| Ceftazidime | Resistant | >=64 |
| Ciprofloxacin | Sensitive | <=0.25 |
| Colistin | Intermediate | 2 |
| Doripenem | Resistant | >=8 |
| Gentamicin | Sensitive | 2 |
| Imipenem | Resistant | >=16 |
| Levofloxacin | Sensitive | 0.5 |
| Meropenem | Resistant | >=16 |
| Piperacillin/Tazobactam | Resistant | >=128 |
| Ticarcillin-clavulanic acid | Resistant | >=128 |
| Tobramycin | Sensitive | 1 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| blaoxa50 | PCR |